Skip to main content
Figure 1 | Journal of Experimental & Clinical Cancer Research

Figure 1

From: Preclinical evaluation of KIT/PDGFRA and mTOR inhibitors in gastrointestinal stromal tumors using small animal FDG PET

Figure 1

Inhibition of tumor growth in Rag2-/-; γcommon -/- male mice injected s.c. with GIST 882 by treatment p.o. with untreated (-□-), imatinib (--), everolimus (), imatinib+everolimus (-♦-), nilotinib (), nilotinib+imatinib (---). The dotted line marks the beginning of therapy. The tumor volumes are expressed as mean ± E.S in cm3. §p > 0.01, *p < 0.05, Student's t test compared with untreated group.

Back to article page